期刊文献+

我院结核科保肝药物利用分析 被引量:1

Analysis of Liver-protective Drug Use in the Department of Tuberculosis of Our Hospital
下载PDF
导出
摘要 目的:了解本院结核科在结核病治疗过程中保肝药物的用药现况及用药趋势。方法:采用WHO推荐使用的DDD数(DDDs)为指标的药物利用研究方法,对本院结核科2006—2008年保肝药物的使用情况进行统计、分析。结果:本院结核科应用的保肝类药品共有12个品种,口服制剂居多。所用的保肝药其用药频度和销售金额基本同步。结论:本院结核科保肝药物应用基本合理。 Objective: To investigate the current situation and the developing trends of liver-protective drug uses in the department of tuberculosis of our hospital during the treatment of tuberculosis.Methods: The defined daily dose(DDD) system for drug utilization was adopted to analyze the consumption of liver-protective drugs in our hospital during 2006-2008.Results:12 varieties of liver-protective drugs are used in the department of tuberculosis,oral preparation occupy the majority.The frequency of drug usage (DDDs) of liver - protective drugs are basically in synchronous with the sales. Conclustion: The use of liver - protective drugs in the department of tuberculosis was basically rational.
作者 张其秀
机构地区 天津市海河医院
出处 《天津药学》 2009年第5期28-30,共3页 Tianjin Pharmacy
关键词 结核病 保肝药 用药分析 tuberculosis liver-protective drug drug use
  • 相关文献

参考文献4

二级参考文献27

  • 1梁晓峰,陈园生,王晓军,贺雄,陈丽娟,王骏,林长缨,白呼群,严俊,崔钢,于竞进.中国3岁以上人群乙型肝炎血清流行病学研究[J].中华流行病学杂志,2005,26(9):655-658. 被引量:967
  • 2Neil Kaplowitz MD. Biochemical and cellular mechanisms of toxic liver injury[J]. Semin Liver Dis,2002,22(2): 137- 144.
  • 3Jahovic N, Cevik H, Sehirli AO, et al. Melatonin prevents methotrexateinduced hepatorenal oxidative injury in rats [ J ]. J Pineal Res, 2003,34 (4): 282 - 287.
  • 4Ohta Y, Kongo M, Kishikawa T. Melatonin exerts a therapeutic effect on cholestatic liver injury in rats with bile duct ligation [ J ]. J Pineal Res,2003,34(2): 119 - 126.
  • 5Adachi N, Ochi T, Tabo E, et al. Prostaglandin E1 improves hepatic encephalopathy produced by ischaemia- reperfusion liver injury in rats[J].Intensive Care Med 2000,26(11):1681- 1684.
  • 6Morioka D, Kubota T, Sekido H, et al. Prostaglandin E1 improved the function of transplanted fatty liver in a rat reduced - size - liver transplantation model under conditions of permissible cold preservat - ion[ J]. Liver Transp1,2003,9( 1 ) :79 - 86.
  • 7Pazzi P, Puviani AC, Dlla Libera M, et al. Bile salt- induced cytotoxicity and ursodeoxycolate cytoprotection: in - vitro study in perifused rat hepatocytes[J]. Eur J Gastroenterol Hepatol, 1997,9(70) :703 - 709.
  • 8Yerushalmi B, Dahl R, Devereaux MW, et al. Bile acid- induced rat hepatocyte apeptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition [ J ]. Hepatology, 2001,33 ( 3 ): 616 -626.
  • 9Kowdley KV. Ursodeoxycholic acid therapy in the hepatobiliary disease[J]. Am J Med,2000,108(6) :481 - 486.
  • 10Keith BD. Ursodeoxycholic acid to inhibit the growth of hepatic metastases[ J ]. Med Hypotheses, 2000,55 (5): 379 - 382.

共引文献41

同被引文献9

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部